Literature DB >> 7205647

The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzene.

R James, P Desmond, A Küpfer, S Schenker, R A Branch.   

Abstract

Rats were pretreated with allyl alcohol, carbon tetrachloride or bromobenzene to induce histopathological evidence of periportal, midzonal to centrilobular, and centrilobular hepatic necrosis. The amount of various drug metabolizing enzyme systems present after necrosis was determined indirectly by measuring the rate of metabolism for specific substrates in vitro. The chemically induced hepatocellular injury of these toxins produced variable but significant alterations in hepatic drug metabolism. The changes in enzymatic activity related well with the area of the lesion produced by each toxin. Thus, these hepatotoxins appear to be useful as probes to determine the hepatolobular distribution of the various drug metabolizing enzyme systems studied. Aniline hydroxylase and p-nitroanisole o-demethylase were concentrated in the midzonal and periportal zones, while aminopyrine N-demethylase was more uniformly distributed along the cytochrome P-450 gradient. Glucuronyltransferase was more heavily concentrated in the periportal-midzonal area, acetyltransferase was centrilobular-midzonal and glutathionetransferase was concentrated in the midzonal region. Thus, as is the case for cytochrome P-450, there appears to be a high degree of regional organization for all of the drug metabolizing enzymes within the hepatic lobule.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205647

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Methods for the study of liver cell heterogeneity.

Authors:  N R Katz
Journal:  Histochem J       Date:  1989 Sep-Oct

3.  A Cytochrome P450-Independent Mechanism of Acetaminophen-Induced Injury in Cultured Mouse Hepatocytes.

Authors:  Kazuhisa Miyakawa; Ryan Albee; Lynda G Letzig; Andreas F Lehner; Michael A Scott; John P Buchweitz; Laura P James; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2015-06-11       Impact factor: 4.030

4.  Fluorescence-microscopic measurement of intracellular cytochrome P-450 enzyme activity (ethoxyresorufin O-de-ethylation) in unfixed liver section.

Authors:  M D Burke; G I Murray; G M Lees
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

5.  Morphological studies on selective acinar liver damage by N-hydroxy-2-acetylaminofluorene and carbon tetrachloride.

Authors:  G M Groothuis; D K Meijer; M J Hardonk
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

6.  Periportal- and perivenous-enriched hepatocyte couplets: differences in canalicular activity and in response to oxidative stress.

Authors:  J C Wilton; J K Chipman; C J Lawson; A J Strain; R Coleman
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

7.  Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases.

Authors:  P Pellinen; F Stenbäck; A Rautio; O Pelkonen; M Lang; M Pasanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

8.  Increased turnover of intrahepatic bile ducts induced by bromobenzene.

Authors:  G Zajicek; R Shamir; J Nordenberg; Y Sidi; N Arber
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

9.  The effects of age and chronic liver disease on the elimination of temazepam.

Authors:  H Ghabrial; P V Desmond; K J Watson; A J Gijsbers; P J Harman; K J Breen; M L Mashford
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.